Cargando…
Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus Infections
Over the years, infectious diseases with high morbidity and mortality disrupted human healthcare systems and devastated economies globally. Respiratory viruses, especially emerging or re-emerging RNA viruses, including influenza and human coronavirus, are the main pathogens of acute respiratory dise...
Autores principales: | Huang, Keke, Ying, Tianlei, Wu, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230756/ https://www.ncbi.nlm.nih.gov/pubmed/35746634 http://dx.doi.org/10.3390/v14061162 |
Ejemplares similares
-
Single-Domain Antibodies As Therapeutics against Human Viral Diseases
por: Wu, Yanling, et al.
Publicado: (2017) -
Recent advances in “universal” influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head
por: Wang, Yulu, et al.
Publicado: (2020) -
Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017) -
Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy
por: Zhu, Xiaoyi, et al.
Publicado: (2021) -
Insights into biological therapeutic strategies for COVID-19
por: Tian, Xiaolong, et al.
Publicado: (2021)